Cheng-Po Huang,Teng-Hai Chen,Kuang Dee Chen,Chun-Tao Su
申请号：
US14299671
公开号：
US09512168B2
申请日:
2014.06.09
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Disclosed herein are compositions and methods for the treatment or prophylaxis of a subject having or susceptible to a kidney disease. The method includes the step of administering to the subject a compound of formula (I) in a dose of about 1 to 10 mg/Kg to improve the glomerular filtration rate (GFR) of the subject for at least 4 folds as compared to the GFR of the subject before treatment,The method further includes the step of administering to the subject an effective amount of lucidenic acid C (LAC), lucidenic acid N (LAN), lucidenic acid E2 (LAE2), lucidenic acid A (LAA), and lucidenic acid D2 (LAD2).
